Flu, RSV and other respiratory illnesses are sending people to urgent care and emergency rooms. In some cases, these patients are ending up with pneumonia. Flu, RSV and other respiratory illnesses are ...

there is some COVID-19 and respiratory syncytial virus infections mixed in, as well, Baker said. At Trident Health System, "we’re experiencing a higher than average incidence of patients with ...

In line with these findings, increased wall stiffening in patients with CoA and prolonged exposure to abnormal haemodynamics was recently suggested.20 However, despite early surgical repair, the ...

Sales of both GSK’s and Pfizer’s vaccines for respiratory syncytial virus dropped significantly in the last three months of 2024, compared the same period one year before. In a earnings report ...

Headquartered in Purchase, New York, Teladoc helps more than 93 million people get virtual medical care and connects patients with doctors, nurses, and therapists. Catapult Health's platform called ...

GSK has been the dominant player in the RSV vaccine market since Arexvy first gained approval in 2023, although Pfizer has made inroads into its market share. While initial launches for both companies ...

Spanish renewables company X-Elio has signed a 10-year Power Purchase Agreement (PPA) to supply 245GWh of clean energy annually to a cohort of four pharmaceutical companies. The cohort, which includes ...

Pfizer Inc. shares fell 2% Tuesday despite the drugmaker topping Wall Street’s revenue and profit estimates in its fourth-quarter results. Analyst firm Edward Jones expects Pfizer’s future ...

Pfizer (PFE) reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations and its stock remained flat after market open. Pfizer reported $63.6 ...

Pfizer expects $1B hit from IRA's Part D redesign and no major M&A in 2025 RSV vaccine Abrysvo specifically floundered in the fourth quarter. The product's sales fell 62% year over year to $198 ...

The FDA said on its website: “FDA has required and approved safety labeling changes to the prescribing information for Abrysvo (Respiratory Syncytial Virus Vaccine) manufactured by Pfizer Inc ...